Marcondes AM et al. showed that low serum AAT levels in BM donors are associated with subsequent GVHD severity [31], and it was carefully suggested that donor leukocytes may carry tolerogenic immune activation profiles when extracted from an AAT-rich environment. Here, SERPINA1 is linked to graft versus host disease.